nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—CYP19A1—Betamethasone—multiple sclerosis	0.249	0.632	CbGbCtD
Nandrolone decanoate—Progesterone—Prednisolone—multiple sclerosis	0.213	0.535	CrCrCtD
Nandrolone decanoate—Testosterone—Prednisolone—multiple sclerosis	0.185	0.465	CrCrCtD
Nandrolone decanoate—CYP19A1—Dexamethasone—multiple sclerosis	0.145	0.368	CbGbCtD
Nandrolone decanoate—Peliosis hepatis—Azathioprine—multiple sclerosis	0.0155	0.139	CcSEcCtD
Nandrolone decanoate—Water retention—Betamethasone—multiple sclerosis	0.00474	0.0425	CcSEcCtD
Nandrolone decanoate—Water retention—Dexamethasone—multiple sclerosis	0.00474	0.0425	CcSEcCtD
Nandrolone decanoate—Water retention—Prednisone—multiple sclerosis	0.00413	0.037	CcSEcCtD
Nandrolone decanoate—Oligospermia—Methotrexate—multiple sclerosis	0.00374	0.0335	CcSEcCtD
Nandrolone decanoate—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—multiple sclerosis	0.00318	0.0512	CbGpPWpGaD
Nandrolone decanoate—MAOB—nerve—multiple sclerosis	0.00309	0.132	CbGeAlD
Nandrolone decanoate—Azoospermia—Methotrexate—multiple sclerosis	0.00291	0.0261	CcSEcCtD
Nandrolone decanoate—Local reaction—Mitoxantrone—multiple sclerosis	0.00284	0.0254	CcSEcCtD
Nandrolone decanoate—MAOA—nerve—multiple sclerosis	0.00263	0.113	CbGeAlD
Nandrolone decanoate—Ethynodiol—PGR—multiple sclerosis	0.00235	0.204	CrCbGaD
Nandrolone decanoate—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.00229	0.0369	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.00229	0.0369	CbGpPWpGaD
Nandrolone decanoate—Norelgestromin—PGR—multiple sclerosis	0.00222	0.193	CrCbGaD
Nandrolone decanoate—Hirsutism—Prednisolone—multiple sclerosis	0.00222	0.0199	CcSEcCtD
Nandrolone decanoate—Hirsutism—Triamcinolone—multiple sclerosis	0.00204	0.0183	CcSEcCtD
Nandrolone decanoate—Hirsutism—Methylprednisolone—multiple sclerosis	0.00204	0.0182	CcSEcCtD
Nandrolone decanoate—Norgestimate—PGR—multiple sclerosis	0.002	0.173	CrCbGaD
Nandrolone decanoate—Mediastinal disorder—Fingolimod—multiple sclerosis	0.00191	0.0171	CcSEcCtD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00188	0.0303	CbGpPWpGaD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00188	0.0303	CbGpPWpGaD
Nandrolone decanoate—Hirsutism—Dexamethasone—multiple sclerosis	0.00185	0.0166	CcSEcCtD
Nandrolone decanoate—Hirsutism—Betamethasone—multiple sclerosis	0.00185	0.0166	CcSEcCtD
Nandrolone decanoate—Furunculosis—Methotrexate—multiple sclerosis	0.00184	0.0165	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Mitoxantrone—multiple sclerosis	0.00179	0.016	CcSEcCtD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—HNRNPA1—multiple sclerosis	0.00175	0.0283	CbGpPWpGaD
Nandrolone decanoate—Etonogestrel—PGR—multiple sclerosis	0.00173	0.15	CrCbGaD
Nandrolone decanoate—Hepatic function abnormal—Azathioprine—multiple sclerosis	0.00161	0.0145	CcSEcCtD
Nandrolone decanoate—Hirsutism—Prednisone—multiple sclerosis	0.00161	0.0144	CcSEcCtD
Nandrolone decanoate—Furuncle—Methotrexate—multiple sclerosis	0.0016	0.0143	CcSEcCtD
Nandrolone decanoate—Hypertension—Fingolimod—multiple sclerosis	0.00159	0.0143	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00157	0.0254	CbGpPWpGaD
Nandrolone decanoate—Acne—Prednisolone—multiple sclerosis	0.00153	0.0137	CcSEcCtD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00142	0.0229	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00142	0.0229	CbGpPWpGaD
Nandrolone decanoate—Acne—Triamcinolone—multiple sclerosis	0.00141	0.0126	CcSEcCtD
Nandrolone decanoate—Acne—Methylprednisolone—multiple sclerosis	0.00141	0.0126	CcSEcCtD
Nandrolone decanoate—CYP19A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.0014	0.0226	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.0014	0.0226	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00139	0.0224	CbGpPWpGaD
Nandrolone decanoate—AR—Coregulation of Androgen receptor activity—ZMIZ1—multiple sclerosis	0.00138	0.0223	CbGpPWpGaD
Nandrolone decanoate—Amenorrhoea—Methylprednisolone—multiple sclerosis	0.00135	0.0121	CcSEcCtD
Nandrolone decanoate—MAOB—brainstem—multiple sclerosis	0.00132	0.0567	CbGeAlD
Nandrolone decanoate—Acne—Dexamethasone—multiple sclerosis	0.00128	0.0115	CcSEcCtD
Nandrolone decanoate—Acne—Betamethasone—multiple sclerosis	0.00128	0.0115	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—PGR—multiple sclerosis	0.00123	0.106	CrCbGaD
Nandrolone decanoate—Amenorrhoea—Dexamethasone—multiple sclerosis	0.00122	0.011	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Betamethasone—multiple sclerosis	0.00122	0.011	CcSEcCtD
Nandrolone decanoate—Fluid retention—Prednisolone—multiple sclerosis	0.00122	0.011	CcSEcCtD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00118	0.019	CbGpPWpGaD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00118	0.019	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00115	0.0186	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00115	0.0186	CbGpPWpGaD
Nandrolone decanoate—MAOA—brainstem—multiple sclerosis	0.00113	0.0484	CbGeAlD
Nandrolone decanoate—Fluid retention—Triamcinolone—multiple sclerosis	0.00113	0.0101	CcSEcCtD
Nandrolone decanoate—Fluid retention—Methylprednisolone—multiple sclerosis	0.00112	0.0101	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—PGR—multiple sclerosis	0.00111	0.018	CbGpPWpGaD
Nandrolone decanoate—Acne—Prednisone—multiple sclerosis	0.00111	0.00998	CcSEcCtD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—PGR—multiple sclerosis	0.0011	0.0177	CbGpPWpGaD
Nandrolone decanoate—MAOA—retina—multiple sclerosis	0.00109	0.0467	CbGeAlD
Nandrolone decanoate—Mediastinal disorder—Cladribine—multiple sclerosis	0.00108	0.0097	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Prednisone—multiple sclerosis	0.00107	0.00956	CcSEcCtD
Nandrolone decanoate—Pruritus—Fingolimod—multiple sclerosis	0.00106	0.00954	CcSEcCtD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—ZMIZ1—multiple sclerosis	0.00102	0.0165	CbGpPWpGaD
Nandrolone decanoate—Fluid retention—Dexamethasone—multiple sclerosis	0.00102	0.00915	CcSEcCtD
Nandrolone decanoate—Fluid retention—Betamethasone—multiple sclerosis	0.00102	0.00915	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—CYP24A1—multiple sclerosis	0.000999	0.0161	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—CYP27B1—multiple sclerosis	0.000999	0.0161	CbGpPWpGaD
Nandrolone decanoate—Norethindrone—PGR—multiple sclerosis	0.000993	0.086	CrCbGaD
Nandrolone decanoate—MAOA—Serotonin Transporter Activity—IL1B—multiple sclerosis	0.000944	0.0152	CbGpPWpGaD
Nandrolone decanoate—MAOB—medulla oblongata—multiple sclerosis	0.000924	0.0395	CbGeAlD
Nandrolone decanoate—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.000908	0.00814	CcSEcCtD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—BDNF—multiple sclerosis	0.000897	0.0145	CbGpPWpGaD
Nandrolone decanoate—Fluid retention—Prednisone—multiple sclerosis	0.000889	0.00797	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.00088	0.0142	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00088	0.00789	CcSEcCtD
Nandrolone decanoate—Jaundice—Mitoxantrone—multiple sclerosis	0.000857	0.00768	CcSEcCtD
Nandrolone decanoate—Oedema—Cladribine—multiple sclerosis	0.000853	0.00765	CcSEcCtD
Nandrolone decanoate—MAOB—midbrain—multiple sclerosis	0.000844	0.0361	CbGeAlD
Nandrolone decanoate—MAOB—spinal cord—multiple sclerosis	0.000824	0.0353	CbGeAlD
Nandrolone decanoate—Irritability—Methylprednisolone—multiple sclerosis	0.00082	0.00735	CcSEcCtD
Nandrolone decanoate—MAOA—medulla oblongata—multiple sclerosis	0.000788	0.0337	CbGeAlD
Nandrolone decanoate—AR—Nuclear Receptors—VDR—multiple sclerosis	0.000778	0.0125	CbGpPWpGaD
Nandrolone decanoate—AR—spinal cord—multiple sclerosis	0.000775	0.0332	CbGeAlD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—VDR—multiple sclerosis	0.000768	0.0124	CbGpPWpGaD
Nandrolone decanoate—Irritability—Betamethasone—multiple sclerosis	0.000745	0.00668	CcSEcCtD
Nandrolone decanoate—Irritability—Dexamethasone—multiple sclerosis	0.000745	0.00668	CcSEcCtD
Nandrolone decanoate—CYP19A1—nervous system—multiple sclerosis	0.000737	0.0316	CbGeAlD
Nandrolone decanoate—MAOA—midbrain—multiple sclerosis	0.00072	0.0308	CbGeAlD
Nandrolone decanoate—CYP19A1—central nervous system—multiple sclerosis	0.00071	0.0304	CbGeAlD
Nandrolone decanoate—MAOA—spinal cord—multiple sclerosis	0.000703	0.0301	CbGeAlD
Nandrolone decanoate—Gynaecomastia—Methotrexate—multiple sclerosis	0.0007	0.00628	CcSEcCtD
Nandrolone decanoate—MAOB—nervous system—multiple sclerosis	0.000694	0.0297	CbGeAlD
Nandrolone decanoate—CYP19A1—Endogenous sterols—POMC—multiple sclerosis	0.000688	0.0111	CbGpPWpGaD
Nandrolone decanoate—MAOA—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000682	0.011	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Cladribine—multiple sclerosis	0.000678	0.00607	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000671	0.0108	CbGpPWpGaD
Nandrolone decanoate—MAOB—central nervous system—multiple sclerosis	0.000668	0.0286	CbGeAlD
Nandrolone decanoate—MAOA—Neuronal System—KCNA3—multiple sclerosis	0.000661	0.0107	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000653	0.0105	CbGpPWpGaD
Nandrolone decanoate—MAOB—cerebellum—multiple sclerosis	0.000653	0.028	CbGeAlD
Nandrolone decanoate—AR—nervous system—multiple sclerosis	0.000653	0.028	CbGeAlD
Nandrolone decanoate—Irritability—Prednisone—multiple sclerosis	0.000649	0.00582	CcSEcCtD
Nandrolone decanoate—AR—central nervous system—multiple sclerosis	0.000629	0.0269	CbGeAlD
Nandrolone decanoate—MAOA—Biological oxidations—CYP27B1—multiple sclerosis	0.000627	0.0101	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—CYP24A1—multiple sclerosis	0.000627	0.0101	CbGpPWpGaD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000615	0.00992	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000611	0.00986	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000611	0.00986	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Cladribine—multiple sclerosis	0.000603	0.00541	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000603	0.00973	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000603	0.00973	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Mitoxantrone—multiple sclerosis	0.000593	0.00532	CcSEcCtD
Nandrolone decanoate—MAOA—nervous system—multiple sclerosis	0.000592	0.0254	CbGeAlD
Nandrolone decanoate—Progesterone—PGR—multiple sclerosis	0.000579	0.0501	CrCbGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000577	0.00931	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000576	0.0093	CbGpPWpGaD
Nandrolone decanoate—MAOA—central nervous system—multiple sclerosis	0.00057	0.0244	CbGeAlD
Nandrolone decanoate—CYP19A1—brain—multiple sclerosis	0.000564	0.0241	CbGeAlD
Nandrolone decanoate—Oedema—Mitoxantrone—multiple sclerosis	0.000561	0.00503	CcSEcCtD
Nandrolone decanoate—MAOA—cerebellum—multiple sclerosis	0.000557	0.0239	CbGeAlD
Nandrolone decanoate—Irritability—Methotrexate—multiple sclerosis	0.000542	0.00486	CcSEcCtD
Nandrolone decanoate—Erectile dysfunction—Prednisone—multiple sclerosis	0.000541	0.00485	CcSEcCtD
Nandrolone decanoate—Rash—Cladribine—multiple sclerosis	0.000538	0.00482	CcSEcCtD
Nandrolone decanoate—Dermatitis—Cladribine—multiple sclerosis	0.000537	0.00482	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000535	0.0048	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	0.000535	0.00863	CbGpPWpGaD
Nandrolone decanoate—MAOB—brain—multiple sclerosis	0.00053	0.0227	CbGeAlD
Nandrolone decanoate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000515	0.00831	CbGpPWpGaD
Nandrolone decanoate—Nausea—Cladribine—multiple sclerosis	0.000507	0.00454	CcSEcCtD
Nandrolone decanoate—AR—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000504	0.00813	CbGpPWpGaD
Nandrolone decanoate—AR—brain—multiple sclerosis	0.000499	0.0214	CbGeAlD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000495	0.00799	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000495	0.00799	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Prednisolone—multiple sclerosis	0.000487	0.00436	CcSEcCtD
Nandrolone decanoate—Oedema—Prednisolone—multiple sclerosis	0.00046	0.00412	CcSEcCtD
Nandrolone decanoate—MAOA—brain—multiple sclerosis	0.000453	0.0194	CbGeAlD
Nandrolone decanoate—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000452	0.00406	CcSEcCtD
Nandrolone decanoate—Hypertension—Triamcinolone—multiple sclerosis	0.000447	0.00401	CcSEcCtD
Nandrolone decanoate—Hypertension—Methylprednisolone—multiple sclerosis	0.000446	0.004	CcSEcCtD
Nandrolone decanoate—Urticaria—Mitoxantrone—multiple sclerosis	0.000445	0.00399	CcSEcCtD
Nandrolone decanoate—Rash—Azathioprine—multiple sclerosis	0.000437	0.00392	CcSEcCtD
Nandrolone decanoate—Dermatitis—Azathioprine—multiple sclerosis	0.000437	0.00392	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000437	0.00705	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	0.000425	0.00685	CbGpPWpGaD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000423	0.00682	CbGpPWpGaD
Nandrolone decanoate—Oedema—Triamcinolone—multiple sclerosis	0.000423	0.00379	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	0.000413	0.00666	CbGpPWpGaD
Nandrolone decanoate—Nausea—Azathioprine—multiple sclerosis	0.000412	0.00369	CcSEcCtD
Nandrolone decanoate—Hypertension—Dexamethasone—multiple sclerosis	0.000406	0.00364	CcSEcCtD
Nandrolone decanoate—Hypertension—Betamethasone—multiple sclerosis	0.000406	0.00364	CcSEcCtD
Nandrolone decanoate—Oedema—Betamethasone—multiple sclerosis	0.000384	0.00344	CcSEcCtD
Nandrolone decanoate—Oedema—Dexamethasone—multiple sclerosis	0.000384	0.00344	CcSEcCtD
Nandrolone decanoate—Urticaria—Prednisolone—multiple sclerosis	0.000365	0.00328	CcSEcCtD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—CD4—multiple sclerosis	0.000363	0.00585	CbGpPWpGaD
Nandrolone decanoate—AR—Nongenotropic Androgen signaling—MAPK1—multiple sclerosis	0.000356	0.00574	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000354	0.00318	CcSEcCtD
Nandrolone decanoate—Hypertension—Prednisone—multiple sclerosis	0.000354	0.00317	CcSEcCtD
Nandrolone decanoate—Rash—Mitoxantrone—multiple sclerosis	0.000353	0.00317	CcSEcCtD
Nandrolone decanoate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000353	0.00317	CcSEcCtD
Nandrolone decanoate—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	0.000342	0.00552	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Triamcinolone—multiple sclerosis	0.000336	0.00301	CcSEcCtD
Nandrolone decanoate—Urticaria—Methylprednisolone—multiple sclerosis	0.000335	0.00301	CcSEcCtD
Nandrolone decanoate—Oedema—Prednisone—multiple sclerosis	0.000334	0.003	CcSEcCtD
Nandrolone decanoate—Nausea—Mitoxantrone—multiple sclerosis	0.000333	0.00299	CcSEcCtD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000319	0.00515	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Betamethasone—multiple sclerosis	0.000305	0.00273	CcSEcCtD
Nandrolone decanoate—Urticaria—Dexamethasone—multiple sclerosis	0.000305	0.00273	CcSEcCtD
Nandrolone decanoate—Pruritus—Triamcinolone—multiple sclerosis	0.000299	0.00268	CcSEcCtD
Nandrolone decanoate—Pruritus—Methylprednisolone—multiple sclerosis	0.000299	0.00268	CcSEcCtD
Nandrolone decanoate—Rash—Prednisolone—multiple sclerosis	0.00029	0.0026	CcSEcCtD
Nandrolone decanoate—Dermatitis—Prednisolone—multiple sclerosis	0.00029	0.0026	CcSEcCtD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—STAT3—multiple sclerosis	0.000281	0.00453	CbGpPWpGaD
Nandrolone decanoate—Norethindrone—ALB—multiple sclerosis	0.000279	0.0242	CrCbGaD
Nandrolone decanoate—Nausea—Prednisolone—multiple sclerosis	0.000273	0.00245	CcSEcCtD
Nandrolone decanoate—Pruritus—Dexamethasone—multiple sclerosis	0.000272	0.00243	CcSEcCtD
Nandrolone decanoate—Pruritus—Betamethasone—multiple sclerosis	0.000272	0.00243	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000271	0.00438	CbGpPWpGaD
Nandrolone decanoate—Rash—Triamcinolone—multiple sclerosis	0.000267	0.00239	CcSEcCtD
Nandrolone decanoate—Dermatitis—Triamcinolone—multiple sclerosis	0.000266	0.00239	CcSEcCtD
Nandrolone decanoate—Rash—Methylprednisolone—multiple sclerosis	0.000266	0.00239	CcSEcCtD
Nandrolone decanoate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000266	0.00238	CcSEcCtD
Nandrolone decanoate—Urticaria—Prednisone—multiple sclerosis	0.000266	0.00238	CcSEcCtD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000265	0.00428	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000259	0.00418	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000256	0.00413	CbGpPWpGaD
Nandrolone decanoate—Nausea—Triamcinolone—multiple sclerosis	0.000251	0.00225	CcSEcCtD
Nandrolone decanoate—Nausea—Methylprednisolone—multiple sclerosis	0.000251	0.00225	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000245	0.00394	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ZNF746—multiple sclerosis	0.000243	0.00391	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—SRM—multiple sclerosis	0.000242	0.00391	CbGpPWpGaD
Nandrolone decanoate—Rash—Dexamethasone—multiple sclerosis	0.000242	0.00217	CcSEcCtD
Nandrolone decanoate—Rash—Betamethasone—multiple sclerosis	0.000242	0.00217	CcSEcCtD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000242	0.0039	CbGpPWpGaD
Nandrolone decanoate—Dermatitis—Betamethasone—multiple sclerosis	0.000242	0.00217	CcSEcCtD
Nandrolone decanoate—Dermatitis—Dexamethasone—multiple sclerosis	0.000242	0.00217	CcSEcCtD
Nandrolone decanoate—Pruritus—Prednisone—multiple sclerosis	0.000236	0.00212	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000235	0.00379	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000235	0.00379	CbGpPWpGaD
Nandrolone decanoate—Nausea—Betamethasone—multiple sclerosis	0.000228	0.00204	CcSEcCtD
Nandrolone decanoate—Nausea—Dexamethasone—multiple sclerosis	0.000228	0.00204	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000226	0.00364	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—POMC—multiple sclerosis	0.000225	0.00362	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Methotrexate—multiple sclerosis	0.000222	0.00199	CcSEcCtD
Nandrolone decanoate—AR—Gene Expression—PTBP1—multiple sclerosis	0.000222	0.00358	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000218	0.00351	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000216	0.00348	CbGpPWpGaD
Nandrolone decanoate—Rash—Prednisone—multiple sclerosis	0.000211	0.00189	CcSEcCtD
Nandrolone decanoate—Dermatitis—Prednisone—multiple sclerosis	0.000211	0.00189	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	0.000206	0.00333	CbGpPWpGaD
Nandrolone decanoate—Nausea—Prednisone—multiple sclerosis	0.000199	0.00178	CcSEcCtD
Nandrolone decanoate—Pruritus—Methotrexate—multiple sclerosis	0.000198	0.00177	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000186	0.00301	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—BCHE—multiple sclerosis	0.000185	0.00299	CbGpPWpGaD
Nandrolone decanoate—Rash—Methotrexate—multiple sclerosis	0.000176	0.00158	CcSEcCtD
Nandrolone decanoate—Dermatitis—Methotrexate—multiple sclerosis	0.000176	0.00158	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—CYP27B1—multiple sclerosis	0.000171	0.00276	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP24A1—multiple sclerosis	0.000171	0.00276	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	0.00017	0.00275	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	0.000169	0.00272	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—STAT3—multiple sclerosis	0.000168	0.00272	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HNRNPA1—multiple sclerosis	0.000168	0.00271	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—U2AF2—multiple sclerosis	0.000168	0.00271	CbGpPWpGaD
Nandrolone decanoate—Nausea—Methotrexate—multiple sclerosis	0.000166	0.00149	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—GPC5—multiple sclerosis	0.000156	0.00252	CbGpPWpGaD
Nandrolone decanoate—Testosterone—ALB—multiple sclerosis	0.000154	0.0133	CrCbGaD
Nandrolone decanoate—MAOA—Metabolism—SRM—multiple sclerosis	0.000152	0.00245	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—PGR—multiple sclerosis	0.000152	0.00245	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—SRM—multiple sclerosis	0.000148	0.00239	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—POMC—multiple sclerosis	0.000141	0.00227	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—POMC—multiple sclerosis	0.000138	0.00222	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ZFP36L1—multiple sclerosis	0.000133	0.00214	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—RRM1—multiple sclerosis	0.000129	0.00209	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000128	0.00207	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000113	0.00183	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP27B1—multiple sclerosis	0.000107	0.00173	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP24A1—multiple sclerosis	0.000107	0.00173	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—VDR—multiple sclerosis	0.000106	0.00171	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	0.000105	0.00169	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	0.000105	0.00169	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PABPC1—multiple sclerosis	0.000103	0.00166	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	0.000103	0.00165	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000102	0.00165	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	0.0001	0.00162	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GPC5—multiple sclerosis	9.8e-05	0.00158	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GPC5—multiple sclerosis	9.56e-05	0.00154	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	9.31e-05	0.0015	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—RPL5—multiple sclerosis	9.29e-05	0.0015	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	8.82e-05	0.00142	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	8.63e-05	0.00139	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	8.5e-05	0.00137	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	8.48e-05	0.00137	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	8.31e-05	0.00134	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TNF—multiple sclerosis	8.21e-05	0.00132	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—RRM1—multiple sclerosis	8.12e-05	0.00131	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—RRM1—multiple sclerosis	7.92e-05	0.00128	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	7.91e-05	0.00128	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	7.51e-05	0.00121	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—BCHE—multiple sclerosis	7.44e-05	0.0012	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—PGR—multiple sclerosis	7.32e-05	0.00118	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.07e-05	0.00114	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL6—multiple sclerosis	6.63e-05	0.00107	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.15e-05	0.000992	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—MAPK1—multiple sclerosis	5.42e-05	0.000874	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.28e-05	0.000852	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—VDR—multiple sclerosis	5.11e-05	0.000825	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.82e-05	0.000777	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—BCHE—multiple sclerosis	4.67e-05	0.000753	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—BCHE—multiple sclerosis	4.55e-05	0.000734	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—APOE—multiple sclerosis	4.47e-05	0.000722	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—MYC—multiple sclerosis	4.22e-05	0.000681	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—POMC—multiple sclerosis	3.84e-05	0.00062	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ALB—multiple sclerosis	3.5e-05	0.000565	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—APOE—multiple sclerosis	2.81e-05	0.000453	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—APOE—multiple sclerosis	2.74e-05	0.000442	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—POMC—multiple sclerosis	2.41e-05	0.000389	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—POMC—multiple sclerosis	2.35e-05	0.000379	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALB—multiple sclerosis	2.2e-05	0.000355	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALB—multiple sclerosis	2.14e-05	0.000346	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—MYC—multiple sclerosis	2.03e-05	0.000328	CbGpPWpGaD
